Molecular Analysis of Thoracic Malignancies

A research study to learn about the biologic features of cancer development, growth, and spread. We are studying components of blood, tumor tissue, normal tissue, and other fluids, such as urine, cerebrospinal fluid, abdominal or chest fluid in patients with cancer. Our analyses of blood, tissue, and/or fluids may lead to improved diagnosis and treatment of cancer by the identification of markers that predict clinical outcome, markers that predict response to specific therapies, and the identification of targets for new therapies.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Eligibility


Inclusion Criteria:

1.Histologically proven diagnosis of non-small cell lung cancer, small cell lung cancer,
thymoma, thymic carcinoma, mesothelioma, or carcinoma of unknown primary consistent with
the presentation of a primary thoracic malignancy.

2.18 years of age or older.

3.Ability to understand and the willingness to sign a written informed consent document.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jordan Preiss
650-723-1002

New Trial Alerts

Receive email alerts when trials open to patients.